{
    "clinical_study": {
        "@rank": "51860", 
        "acronym": "NoHarm", 
        "arm_group": {
            "arm_group_label": "Hyaluronic acid", 
            "arm_group_type": "Experimental", 
            "description": "Hyaluronic acid will be injected in the space between the prostate and rectum prior to radiotherapy to perform a dorsal movement of rectum."
        }, 
        "brief_summary": {
            "textblock": "The dominating problem after local radiotherapy of prostate cancer is rectal toxicity. If\n      the rectum could be completely moved out of the treated volume, a substantial decrease of\n      rectal toxicity seems reasonable. In this study we will develop and evaluate a new\n      transrectal injection technique where hyaluronic acid (HA) is injected in the space between\n      the prostate and the rectum prior to external beam radiotherapy to increase the physical\n      distance between prostate and rectum."
        }, 
        "brief_title": "To Evaluate the Technique and Effects of Separating the Prostate and Rectum With Hyaluronic Acid During Radiotherapy", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Prostatic Cancer", 
        "condition_browse": {
            "mesh_term": "Prostatic Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologically verified prostatic cancer\n\n          -  Low or intermediate risk prostatic cancer\n\n          -  Lymph node negative\n\n          -  Suitable for radiotherapy\n\n        Exclusion Criteria:\n\n          -  Earlier treatment for prostatic cancer\n\n          -  Unable to co-operate or suffering from any other form of disease that would interfere\n             with the planned treatment"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01787630", 
            "org_study_id": "NoHarm1"
        }, 
        "intervention": {
            "arm_group_label": "Hyaluronic acid", 
            "description": "Injection in connection with ultrasound", 
            "intervention_name": "Hyaluronic acid", 
            "intervention_type": "Device", 
            "other_name": "NASHA Spacer Gel"
        }, 
        "intervention_browse": {
            "mesh_term": "Hyaluronic Acid"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Prostatic cancer", 
            "Radiotherapy", 
            "Hyaluronic acid"
        ], 
        "lastchanged_date": "February 6, 2013", 
        "location": [
            {
                "contact": {
                    "email": "magnus.lagerlund@ltkalmar.se", 
                    "last_name": "Magnus Lagerlund, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Kalmar", 
                        "country": "Sweden", 
                        "zip": "SE-39244"
                    }, 
                    "name": "Department of oncology, Kalmar Hospital"
                }, 
                "investigator": {
                    "last_name": "Magnus Lagerlund, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sundsvall", 
                        "country": "Sweden", 
                        "zip": "SE-851 86"
                    }, 
                    "name": "Department of oncilogy, Sundsvall Hospital"
                }, 
                "investigator": {
                    "last_name": "Lars Beckman, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "anders.widmark@onkologi.umu.se", 
                    "last_name": "Anders Widmark, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Ume\u00e5", 
                        "country": "Sweden", 
                        "zip": "SE-901 85"
                    }, 
                    "name": "Department of oncology, University Hospital"
                }, 
                "investigator": {
                    "last_name": "Anders Widmark, Prof, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "1", 
        "official_title": "Initiating Phase II-III Study to Evaluate the Technique and Effects of Separating the Prostate From the Rectum With Hyaluronic Acid During Radiotherapy", 
        "overall_contact": {
            "email": "anders.widmark@onkologi.umu.se", 
            "last_name": "Anders Widmark, Prof MD", 
            "phone": "+46 90 785", 
            "phone_ext": "2857"
        }, 
        "overall_official": {
            "affiliation": "Umea university, dept of oncology", 
            "last_name": "Anders Widmark, Prof MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Medical Products Agency", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measurement on the remaining volume of HA by MRI", 
            "measure": "Remaining volume of HA", 
            "safety_issue": "Yes", 
            "time_frame": "24 month after end of radiotherapy"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01787630"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ume\u00e5 University", 
            "investigator_full_name": "Anders Widmark", 
            "investigator_title": "Professor, MD", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "Patient evaluation with questionnaires regarding Quality of Life and side effects after radiotherapy", 
            "measure": "Quality of life", 
            "safety_issue": "No", 
            "time_frame": "24 month after end of radiotherapy"
        }, 
        "source": "Ume\u00e5 University", 
        "sponsors": {
            "collaborator": {
                "agency": "University Hospital, Ume\u00e5", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Anders Widmark", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}